Adagene Presents Two Posters with New Insights on Increased Therapeutic Index for Masked Anti-CTLA-4 SAFEbody ADG126 and Data Reinforcing Clinical Safety and Efficacy for ADG126 as Monotherapy and in Combination with Anti-PD-1 Therapy at Society for Immunotherapy of Cancer th Annual Meeting
| ADAG Stock | USD 1.96 0.11 5.95% |
Roughly 55% of Adagene's stockholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Adagene suggests that some traders are interested. The current market sentiment, together with Adagene's historical and current headlines, can help investors time the market. In addition, many technical investors use Adagene stock news signals to limit their universe of possible portfolio assets.
- Improved safety and efficacy profiles for ADG126 versus ipilimumab driven by precision masking, novel epitope-dependent antibody-dependent cellular...
Read at globenewswire.com
 |
Adagene Fundamental Analysis
We analyze Adagene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adagene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adagene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Adagene is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Adagene Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adagene stock to make a market-neutral strategy. Peer analysis of Adagene could also be used in its relative valuation, which is a method of valuing Adagene by comparing valuation metrics with similar companies.
Peers
Adagene Related Equities
| RZLT | Rezolute | 5.32 | ||||
| ANAB | AnaptysBio | 3.83 | ||||
| MOLN | Molecular Partners | 0.00 | ||||
| PMVP | Pmv Pharmaceuticals | 1.10 | ||||
| MLYS | Mineralys Therapeutics, | 1.14 | ||||
| JANX | Janux Therapeutics | 2.23 | ||||
| ANTX | AN2 Therapeutics | 2.54 | ||||
| ANEB | Anebulo Pharmaceuticals | 2.78 | ||||
| ACRV | Acrivon Therapeutics, | 5.98 |
Complementary Tools for Adagene Stock analysis
When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |